Display options
Share it on

Clin Transl Med. 2021 Apr;11(4):e363. doi: 10.1002/ctm2.363.

Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss.

Clinical and translational medicine

Silvia Murillo-Cuesta, Adelaida M Celaya, Blanca Cervantes, Jose M Bermúdez-Muñoz, Lourdes Rodríguez-de la Rosa, Julio Contreras, Isabel Sánchez-Pérez, Isabel Varela-Nieto

Affiliations

  1. Biomedical Research Networking Center on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
  2. Institute for Biomedical Research "Alberto Sols", Spanish National Research Council-Autonomous University of Madrid, Spain.
  3. Hospital La Paz Institute for Health Research, Madrid, Spain.
  4. Anatomy and Embriology Department, Faculty of Veterinary, Universidad Complutense de Madrid, Madrid, Spain.
  5. Biochemistry Department, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain.

PMID: 33931965 PMCID: PMC8021538 DOI: 10.1002/ctm2.363

[No abstract available.]

References

  1. Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2413-2422 - PubMed
  2. EMBO Mol Med. 2017 Jan;9(1):7-26 - PubMed
  3. Cancer Res. 2004 Dec 15;64(24):9217-24 - PubMed
  4. Nat Commun. 2017 Nov 21;8(1):1654 - PubMed
  5. Trends Mol Med. 2019 Dec;25(12):1123-1132 - PubMed
  6. Int J Audiol. 2019 Nov;58(11):685-695 - PubMed
  7. J Clin Med. 2019 Sep 14;8(9): - PubMed
  8. J Vis Exp. 2017 Mar 8;(121): - PubMed
  9. Protein Cell. 2015 Nov;6(11):833-43 - PubMed
  10. PLoS One. 2014 Oct 20;9(10):e110979 - PubMed

Publication Types